COVID-19 Serotherapy [sérologická léčba covidu-19]
- Terms
-
Convalescent Plasma Treatment for Covid-19
Convalescent Serum Treatment for Covid-19
Coronavirus Disease 2019 Serotherapy
Coronavirus Disease-19 Serotherapy
COVID-19 Convalescent Plasma Treatment
Covid-19 Convalescent Sera Treatment
COVID-19 Convalescent Serum Treatment
COVID-19 Hyperimmune Globulin Therapy
COVID-19 Serum Therapy
COVID19 Hyperimmune Globulin Therapy
COVID19 Serotherapy
COVID19 Serum Therapy
Hyperimmune Globulin Therapy for COVID-19
SARS-CoV-2 Convalescent Plasma Treatment
SARS-CoV-2 Convalescent Sera Treatment
SARS-CoV-2 Convalescent Serum Treatment
Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
- DUI
- D000093522 MeSH Browser
- CUI
- M000754225
- History note
- 2023 (2020)
- Public note
- 2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022
Allowable subheadings
- AE
- adverse effects 0
- CL
- classification 0
- EC
- economics 0
- ES
- ethics 0
- HI
- history 0
- IS
- instrumentation 0
- MT
- methods 0
- MO
- mortality 0
- NU
- nursing 0
- PX
- psychology 0
- ST
- standards 0
- SN
- statistics & numerical data 0
- TD
- trends 0
- VE
- veterinary 0